BioCentury
ARTICLE | Clinical News

Scynexis, Merck preclinical data

October 11, 2010 7:00 AM UTC

In mice inoculated with Aspergillus fumigatus spores, MK-3118 initiated within 15-30 minutes after challenge and continued twice-daily for 7 days led to survival rates of up to 90% at day 14 post-infe...